U.S. Markets closed

Innovation Pharmaceuticals Inc. (IPIX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2803-0.0091 (-3.16%)
At close: 3:50PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -0.43
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.5000
52 Week Low 30.1600
50-Day Moving Average 30.2876
200-Day Moving Average 30.2499

Share Statistics

Avg Vol (3 month) 31.18M
Avg Vol (10 day) 3889.67k
Shares Outstanding 5418.07M
Implied Shares Outstanding 6N/A
Float 367.72M
% Held by Insiders 112.04%
% Held by Institutions 10.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-30,073.91%

Management Effectiveness

Return on Assets (ttm)-54.37%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)23k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)423k
EBITDA -6.54M
Net Income Avi to Common (ttm)-9.82M
Diluted EPS (ttm)-0.0320
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.19M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)3.86M
Total Debt/Equity (mrq)112.43
Current Ratio (mrq)1.22
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-7.42M
Levered Free Cash Flow (ttm)-6.44M